Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an ageing population. The only currently recommended...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119308099 |
id |
doaj-eb15bf40b14340f8acef03b5a11cded9 |
---|---|
record_format |
Article |
spelling |
doaj-eb15bf40b14340f8acef03b5a11cded92021-06-09T05:52:16ZengElsevierAnnals of Hepatology1665-26812015-01-01141121126Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case seriesLudovico Abenavoli0Valentina Peta1Natasa Milic2Department of Health Sciences, University Magna Græcia, Catanzaro, Italy; Correspondence and reprint request:Department of Health Sciences, University Magna Græcia, Catanzaro, ItalyDepartment of Pharmacy, University of Novi Sad, Novi Sad, SerbiaNon-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an ageing population. The only currently recommended treatment for NAFLD is lifestyle modification. However, literature reports pre-clinical and clinical studies on the use of antioxidant supplementation in NAFLD. A new antioxidant complex, called Bilirel (BIL) (Pharmaluce, Republic of San Marino), have recently introduced in the Italian market. However no data are reported on his effects on liver steatosis. Here we report on a cases series of seven overweight patients with NAFLD, in which the association of an Italian Mediterranean diet, increased physical activity, and daily administration of two pills of BIL for 6 weeks, have induced the rapid improvement of fatty liver accumulation, glucose and lipid metabolism, and weight reduction.http://www.sciencedirect.com/science/article/pii/S1665268119308099Non-alcoholic fatty liver diseaseSteatosisMediterranean dietAntioxidantInsulin resistance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ludovico Abenavoli Valentina Peta Natasa Milic |
spellingShingle |
Ludovico Abenavoli Valentina Peta Natasa Milic Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series Annals of Hepatology Non-alcoholic fatty liver disease Steatosis Mediterranean diet Antioxidant Insulin resistance |
author_facet |
Ludovico Abenavoli Valentina Peta Natasa Milic |
author_sort |
Ludovico Abenavoli |
title |
Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series |
title_short |
Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series |
title_full |
Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series |
title_fullStr |
Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series |
title_full_unstemmed |
Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series |
title_sort |
lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series |
publisher |
Elsevier |
series |
Annals of Hepatology |
issn |
1665-2681 |
publishDate |
2015-01-01 |
description |
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an ageing population. The only currently recommended treatment for NAFLD is lifestyle modification. However, literature reports pre-clinical and clinical studies on the use of antioxidant supplementation in NAFLD. A new antioxidant complex, called Bilirel (BIL) (Pharmaluce, Republic of San Marino), have recently introduced in the Italian market. However no data are reported on his effects on liver steatosis. Here we report on a cases series of seven overweight patients with NAFLD, in which the association of an Italian Mediterranean diet, increased physical activity, and daily administration of two pills of BIL for 6 weeks, have induced the rapid improvement of fatty liver accumulation, glucose and lipid metabolism, and weight reduction. |
topic |
Non-alcoholic fatty liver disease Steatosis Mediterranean diet Antioxidant Insulin resistance |
url |
http://www.sciencedirect.com/science/article/pii/S1665268119308099 |
work_keys_str_mv |
AT ludovicoabenavoli lifestylechangesassociatedwithanewantioxidantformulationinnonalcoholicfattyliverdiseaseacaseseries AT valentinapeta lifestylechangesassociatedwithanewantioxidantformulationinnonalcoholicfattyliverdiseaseacaseseries AT natasamilic lifestylechangesassociatedwithanewantioxidantformulationinnonalcoholicfattyliverdiseaseacaseseries |
_version_ |
1721388996297228288 |